Lawrence T. Kennedy Jr bought $41k of BDSX
director, owner at BIODESIX INC. 35,000 shares at an average of $1.16, traded Nov 21, 2024, filed Nov 22, 2024.
Score components
- +15RoleDirector
- +6Trade size$41k at market
- -5Relative to holdingsUnder 1% of holdings (0.3%)
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +22.7%, 3m -31.1%, 6m -73.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-24-003257, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | POpen-market purchase Common Stockindirect: By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 | +35,000 | $1.16 | $41k | 10,411,024 | Nov 22, 2024 |
Related signals
Other insiders at BIODESIX INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | BDSXbuy BIODESIX INC | Jack W Schuler owner, other | $367k 15,000 shares | +3% | |
| 40Moderate | BDSXbuy BIODESIX INC | Jack W Schuler owner, other | $666k 27,600 shares | +5% | |
| 15Weak | BIODESIX INC | Kieran O'Kane Chief Commercial Officer | $6,835 535 shares | -5% | |
| 15Weak | BIODESIX INC | Gary Anthony Pestano Chief Development Officer | $7,103 556 shares | -5% | |
| 25Weak | BIODESIX INC | Scott Hutton President & CEO | $19k 1,490 shares | -3% | |
| 22Weak | BIODESIX INC | Robin Harper Cowie CFO, Sec'y & Treasurer | $6,835 535 shares | -3% | |
| 20Weak | BIODESIX INC | Chris Vazquez Chief Accounting Officer | $2,696 211 shares | -12% | |
| 31Weak | BIODESIX INC | Scott Hutton President & CEO | $36k 3,559 shares | -7% | |
| 15Weak | BIODESIX INC | Gary Anthony Pestano Chief Development Officer | $5,445 540 shares | -5% | |
| 15Weak | BIODESIX INC | Kieran O'Kane Chief Commercial Officer | $5,889 584 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.